Durham, NC, United States of America

Matthew D Orr

This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew D Orr. Retrieved from https://idiyas.com/inventor/matthew-d-orr-0iz1wj1i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthew D Orr: Innovator in Imaging Agents

Introduction

Matthew D Orr is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of medical imaging, particularly through his innovative work on choline analogs. His research focuses on developing advanced imaging agents that can aid in the noninvasive detection of neoplasms and other pathophysiologies.

Latest Patents

Matthew D Orr holds a patent for his invention titled "18F-labeled choline analogs." This invention relates to F-labeled choline analogs and methods of using them as imaging agents, specifically for positron emission tomography (PET) imaging. The patent outlines the synthesis of these analogs and their applications in detecting and localizing various medical conditions that affect choline processing in the body. He has 1 patent to his name.

Career Highlights

Matthew D Orr is affiliated with Duke University, where he continues to advance his research in medical imaging. His work has garnered attention for its potential to improve diagnostic techniques in healthcare.

Collaborations

Some of his notable coworkers include R Edward Coleman and Steven W Baldwin, who have collaborated with him on various research projects.

Conclusion

Matthew D Orr's contributions to the field of imaging agents highlight his innovative spirit and dedication to advancing medical technology. His work has the potential to significantly impact the way neoplasms and related conditions are diagnosed and treated.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…